Specifically, lncRNA BACE1-antisense (BACE1-AS) has been identified to enhance both the stability of BACE1 mRNA and its protein presence in neuronal cells, culminating in augmented Aβ production in individuals diagnosed with AD [24]. This evidence concerns the gene BACE1 and Alzheimer disease.